Moonlens by CLCA

Moonlens is an innovative overnight orthokeratology system that uses a progressive lens design and a proprietary fitting algorithm for patient customisation.

Moonlens integrates seamlessly with KATTCloud, a platform designed specifically for optometrists. KATTCloud streamlines the entire process, from designing and troubleshooting lenses to ordering and tracking them – all in one convenient location.

Contact: Contact Lens Centre Australia (AUS) 1800 125 023

MiSight 1 Day by CooperVision

MiSight 1 day from CooperVision remains the only contact lens with approval from the United States Food and Drug Administration for slowing the progression of childhood myopia.

Now available in higher prescriptions, the range covers -0.25D to -10.00D (0.50D steps after -6.00D), allowing even more children to benefit from myopia management.

MiSight 1 day contact lenses are backed by the longest-running soft contact lens study among children.1 This extraordinary study confirmed the overwhelming preference children have for contact lenses, giving optometrists the evidence to support their decision making and parental conversations.

Contact: CooperVision (AUS)1800 655 480 or (NZ) 0800 606 060

Reference Lumb, E., Sulley, A., Chamberlain, P., et al., Six years of wearer experience in children participating in a myopia control study of MiSight 1 day. Cont Lens Anterior Eye. 2023 Aug;46(4):101849. DOI: 10.1016/j.clae.2023.101849.

MyoMe and MyoStock by CR Labs

CR Labs offers a comprehensive range of non-intrusive, cost-effective myopia management solutions with its innovative MyoMe and MyoStock lenses. MyoMe lenses are designed to manage myopia by using advanced Myo-FreeForm technology to reduce peripheral hyperopic defocus, thereby slowing down axial length elongation and myopia progression. This lens features a central clear zone, specific treatment zones that take retinal asymmetry into account, and a near addition.

MyoStock employs hexagonal implication defocus segments (HIDS) technology to manage myopia progression effectively.

Contact: CR Labs (AUS) 1800 334 867

MyoMe and MyoStock by CR Labs

Stellest by Essilor

According to Norbert Gorny, Chief Scientific Officer at EssilorLuxottica, “Long-term clinical data is essential to showcase the continued efficacy and performance of the lens in children”. Recently released five-year data shows continued efficacy of Stellest lenses in controlling myopia progression and axial elongation.

The results showed:

• Over five years, Essilor Stellest lenses slowed myopia progression by 1.75D*1 and axial elongation by 0.72mm**1 on average for all subjects, compared to the extrapolated control group, and

• The efficacy was sustained in older children (up to 18 years old), as the children who completed the fifth-year study were aged between 13–18 years.

The study will continue for two more years. 

Contact: Essilor Account Manager

*Compared to the 60-month progression of the extrapolated control group (predicted average annual decrease in SER by 9.7% based on the initial two-year control group). Smotherman, C., Brennan, N.A., Bullimore, M.A., et al., Influence of age and race on refractive error progression in myopic children. Invest. Ophthalmol. Vis. Sci. 2023;64(8):811. **Compared to the 60-month progression of the extrapolated control group (predicted average annual decrease in AL by 15% based on the initial two-year control group). Shamp, W., Brennan, N.A., Maynes, E., et al., Influence of age and race on axial elongation in myopic children.

Reference
1. Li, X., Huang, Y., Bao, J., et al., Myopia control efficacy of spectacle lenses with highly aspherical lenslets: results of a five-year follow-up study. ARVO Annual Meeting, Seattle. 2024. Available at: eppro02.ativ.me. [Accessed 24 May 2024].

EyeSpace

EyeSpace is at the frontier of contact lens design and aims to make rigid contact lens prescribing easy by supporting your myopia management journey.

MyoStock employs hexagonal implication defocus segments (HIDS) technology to manage myopia progression effectively.

Scan the QR Code to book a time and find out more about:

• Forge orthokeratology: advanced digitally designed orthokeratology lens made to be worn overnight, and

• EyeSpace Bespoke: completely customised daily wear rigid contact lenses.

Visit: eye.space

Gelflex Ortho-K

Orthokeratology (OK) is a proven and effective option in the myopia management landscape. Gelflex offers various OK options for optometrists in Australia and New Zealand including Gelflex Ortho-K , Paragon, and Euclid.

The Gelflex Ortho-K lens now offers multiple diameters and control curves for effective myopia treatment, and like all other Gelflex products, is supported by the company’s experienced technical support team.

Gelflex is now the exclusive distribution and manufacturing partner for the powerful WAVE software in Australia and New Zealand. The WAVE Contact Lens System is an innovative and sophisticated custom contact lens software platform for designing scleral, OK, and GP contact lenses.

Contact: Gelflex (AUS) 1800 335 559

MiyoSmart by HOYA

MiyoSmart provides a robust and wide spectrum of evidence, empowering you to meet the needs of diverse patients with confidence.

The award winning1-3 MiyoSmart spectacle lenses were shown to slow myopia progression by 60% in children aged eight to 13.4

Furthermore, the findings of the six-year, longterm follow-up study proved that the MiyoSmart spectacle lens myopia control effect is sustained over time for children wearing the lens, with an average cumulative myopia progression less than 1.00D and axial elongation 0.6 mm over six years in children that wore MiyoSmart for the duration of the study.5

It was also confirmed that patients who stopped wearing the MiyoSmart spectacle lens showed no rebound effects.5

CLEAR AND SUN

MiyoSmart lenses are available in clear and sun options, to suit patients’ needs.

• MiyoSmart Chameleon, HOYA’s photochromic spectacle lenses, rapidly adapt to the level of sunlight, providing children with as much protection as they need at any time and place.6,7,8

• MiyoSmart Sunbird, HOYA’s polarised spectacle lenses, are the ideal addition to Miyosmart clear spectacle lenses for extra protection from intense sunlight and glare.7,9

Contact: HOYA Account Manager

References

1 .Winners, Grand Prix of the International Exhibitions Geneva, Available at: inventions-geneva.ch/en/winners [accessed Feb 2023].
2.Winners 2020. Silmo Paris. 2020. Available at: en.silmoparis.com/SILMO-d-Or/SILMO-d-Or-Awards/2020Winners# [accessed Feb 2023].
3. Winners best lens design 2023. OMEGA Melbourne, 2023 Available at: odma.com.au/odma-general-news/odma-2023awards-for-excellence-winners [accessed June 2024].
4. Lam, C.S.Y., Tang, W.C., To, C.H., et al., Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a two-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363–8.
5. Lam, C.S.Y., Tang, W.C., To, C.H., et al., Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for six years. Sci Rep. 2023;13(1):5475.
6. HOYA data on file. PSF test on MiyoSmart clear and sun spectacle lenses. 06/2022.
7. HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiyoSmart clear and polarised lenses. 02/2023. Tests were conducted at room temperature (23° C).
8. HOYA data on file. Lens performance validation test for MiyoSmart photochromic lenses – activation and deactivation. 02/2023. Tests were conducted at room temperature (23° C).
9. World Society of Paediatric Ophthalmology and Strabismus. Sunlight exposure and children’s eyes consensus statement. 2016. Available at: wspos.org/wspossunlight-exposurechildrens-eyes-consensus-statement/ [accessed July 2023].

MyCon by Rodenstock

Whether it’s tablets, computers or homework, today’s kids focus more on things right in front of them rather than spending time outdoors. This behaviour is leading to more and more children developing myopia.

Rodenstock My Con provides an ideal solution for myopia control. These children’s lenses are precisely designed to correct myopia, ensure sharp vision, and counteract the progression of myopia.

My Con lenses from Rodenstock are available in a variety of indices in clear, tinted, ColorMatic, and polarised options, and can be flexibly adapted to a child’s needs. Most importantly, they are both thinner and lighter than many other myopia lenses on the market.

Contact: Rodenstock (AUS) 02 9748 0988

ZEISS MyoCare

ZEISS MyoCare lenses consist of cylindrical annular refractive elements (CARE) technology with alternating defocus and correction zones that expand towards the periphery of the lens.

The unique ZEISS ClearFocus design on the back surface prevents hyperopic defocus, independent of gaze direction.

At the 2024 Association for Research in Vision and Ophthalmology Conference (ARVO 24), ZEISS presented results1 from two on-going multi-centre trials in China and Europe:

• The use of ZEISS MyoCare lenses was shown to significantly slow progression of myopia compared to the use of single-vision lenses.

• After 12 months of lens wear, the difference in myopia progression with ZEISS Myo Care in Asian children compared with single vision was spherical equivalent: 0.31D and axial length: 0.13 mm.

The data represents a comprehensive evaluation of ZEISS MyoCare across multiple sites involving large samples and ethnic groups.

ZEISS has expanded its product range from 1.5, 1.59, and 1.6 to include the 1.67 index, available with a six-month unconditional warranty.

Contact: ZEISS Account Manager

Reference
1. Review of Myopia Management, ZEISS shares data on myocare efficacy at ARVO 2024 (web article, 8 May 2024) available at: reviewofmm.com/zeiss-shares-data-onmyocare-efficacy-at-arvo-2024 [accessed June 2024].